Health Care M&A Weekly Deals, The Week Ending November 17, 2017

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Janssen Biotech Inc. License to 6 bispecific antibodies $50 million ITUS Corporation License to CAR-T technology N/A Excision Biotherapeutics License to CRISPR gene editors N/A Monopar Therapeutics, Inc.... Read More »

Health Care M&A Weekly Deals, The Week Ending November 10, 2017

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price OncoResponse Paganini Biopharma N/A CERENIS Therapeutics LYPRO Biosciences Inc. N/A ClearLight Diagnostics, LLC License to IP relating to CLARITY N/A Home Health Care & Hospice Acquirer Target Price... Read More »

Health Care M&A Weekly Deals, The Week Ending November 3, 2017

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Mereo BioPharma Group Ltd. License to AZD9668 $5 million Vaxart, Inc. Aviragen Therapeutics, Inc. $60 million Synthetic Genomics, Inc. Collaboration on RNA-based vaccines N/A Sarepta Therapeutics License... Read More »
Stat of the Week: October Deal Volume +9%

Stat of the Week: October Deal Volume +9%

After a few months of slow going, healthcare deal volume revved up in October. Although it’s the start of the typically busy fourth quarter, we’ve learned not to expect past performance to indicate future results. Preliminary data shows 130 transactions were announced, up 9% compared with the 119 deals announced in both September 2017 and October 2016. Deal value was comparatively strong, as well. The $12.1 billion reported for October 2017 is 4% higher than the previous month ($11.7 billion), but 8% lower than the same month a year ago ($13.2 billion). Three deals came with $1 billion-plus prices and a combined total of $8.5 billion, or 70% of the month’s spending. By contrast, September... Read More »

Health Care M&A Weekly Deals, The Week Ending October 27, 2017

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care     Acquirer Target Price Meridian Behavioral Health New Beginnings Minnesota N/A Biotechnology     Acquirer Target Price Finch Therapeutics Crestovo N/A AbbVie Inc. Collaboration on... Read More »

Health Care M&A Weekly Deals, The Week Ending October 20, 2017

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care     Acquirer Target Price Invo Healthcare Autism Home Support Services N/A Biotechnology     Acquirer Target Price Syndax Pharmaceuticals, Inc. License to portfolio of small molecule... Read More »